Mass General North Shore Cancer Center — Danvers, Massachusetts

Mass General North Shore Cancer Center is a clinical research site located in Danvers, Massachusetts, United States 01923.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Mass General North Shore Cancer Center has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, HER2-positive Breast Cancer.

Sponsors: Dana-Farber Cancer Institute, Stemline Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General North Shore Cancer Center?

Mass General North Shore Cancer Center has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General North Shore Cancer Center conducted?

Mass General North Shore Cancer Center has 3 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, HER2-positive Breast Cancer.

Is Mass General North Shore Cancer Center accredited by Crixeo Health?

Mass General North Shore Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General North Shore Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.